STOCK TITAN

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Maravai LifeSciences, Inc. (NASDAQ: MRVI) announces its participation in investor conferences in May and June 2024. CEO Trey Martin and CFO Kevin Herde will engage in fireside chats at the RBC Healthcare Conference and Goldman Sachs Healthcare Conference, providing a live webcast for interested parties.

Positive
  • Maravai LifeSciences showcasing its presence and engagement in investor conferences indicates transparency and openness towards investors.

  • Live webcasts of the presentations offer accessibility to a wider audience, increasing transparency and investor relations.

Negative
  • None.

SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the months of May and June.

On May 15, 2024, at 3:15 p.m. EST, Trey Martin, Chief Executive Officer and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the RBC Healthcare Conference in New York City, NY.

On June 11, 2024, at 1:20 p.m. EST, Trey Martin, Chief Executive Officer and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Healthcare Conference in Miami Beach, FL.

A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events. An archived version of the webcast will also be available on the Maravai website after the event is completed.

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.

For more information about Maravai LifeSciences, visit www.maravai.com.


FAQ

When will Maravai LifeSciences participate in investor conferences in May and June 2024?

Maravai LifeSciences will participate in investor conferences in May and June 2024, with CEO Trey Martin and CFO Kevin Herde engaging in fireside chats.

What conferences will Maravai LifeSciences attend in May and June 2024?

Maravai LifeSciences will attend the RBC Healthcare Conference in New York City, NY on May 15, 2024, and the Goldman Sachs Healthcare Conference in Miami Beach, FL on June 11, 2024.

Where can interested parties access the live webcasts of Maravai LifeSciences' presentations?

Interested parties can access the live webcasts of Maravai LifeSciences' presentations on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events.

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Stock Data

1.51B
98.47M
2.37%
102.51%
3.87%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
SAN DIEGO

About MRVI

maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri